In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Large Comparative Trials Deserve More Support, FDAer Says

Executive Summary

Thrombolytic agent mortality studies demonstrate the value of large head-to-head trials to detect small outcomes differences between drugs, Center for Drug Evaluation & Research Acting Deputy Director Mark Goldberger said
Advertisement

Related Content

AHRQ Comparative Research Agenda Will Start With Rx Drugs
Genentech TNKase/ReoPro Study Looking At New Use For Activase Successor
Genentech TNKase/ReoPro Study Looking At New Use For Activase Successor
Advertisement
UsernamePublicRestriction

Register

PS043867

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel